Table S11 Location of respondents and eligible sites | | Routine primary care data | Genetic ‘Biobank’ | Cancer registry | Use-case location |
|---|
| Countries | EU | N | n | N | n | N | n | Primary Care + Genetic/Biobank | Primary Care + Cancer Registry |
|---|
| Austria | X | 5 | 1 | 3 | 1 | 4 | 0 | X | |
| Belgium | X | 10 | 2 | 3 | 0 | 3 | 0 | | |
| Bulgaria | X | 0 | 0 | 0 | 0 | 0 | 0 | | |
| Croatia | | 1 | 1 | 0 | 0 | 1 | 1 | | X |
| Cyprus | X | 0 | 0 | 0 | 0 | 0 | 1 | | |
| Czech Republic | X | 0 | 0 | 0 | 0 | 0 | 2 | | |
| Denmark | X | 4 | 1 | 1 | 0 | 1 | 0 | | |
| Estonia | X | 3 | 0 | 0 | 1 | 1 | 0 | | |
| Finland | X | 1 | 1 | 1 | 0 | 1 | 1 | | X |
| France | X | 11 | 3 | 24 | 1 | 13 | 1 | X | X |
| Germany | X | 9 | 4 | 18 | 0 | 4 | 1 | | X |
| Greece | X | 4 | 0 | 1 | 0 | 1 | 1 | | |
| Hungary | X | 2 | 0 | 0 | 0 | 0 | 0 | | |
| Iceland | | 2 | 0 | 5 | 1 | 2 | 0 | | |
| Ireland | X | 4 | 1 | 1 | 0 | 1 | 1 | | X |
| Italy | X | 15 | 3 | 27 | 1 | 18 | 0 | X | |
| Latvia | X | 0 | 0 | 1 | 1 | 1 | 0 | | |
| Lithuania | X | 1 | 0 | 1 | 1 | 1 | 0 | | |
| Luxembourg | X | 1 | 0 | 0 | 0 | 0 | 0 | | |
| Malta | X | 1 | 1 | 3 | 0 | 2 | 0 | | |
| Norway | | 5 | 1 | 2 | 0 | 2 | 1 | | X |
| Poland | X | 0 | 0 | 1 | 0 | 4 | 1 | | |
| Portugal | X | 6 | 0 | 2 | 1 | 3 | 1 | | |
| Romania | X | 7 | 0 | 2 | 0 | 1 | 0 | | |
| Russia | | 2 | 0 | 0 | 0 | 1 | 0 | | |
| Slovakia | X | 1 | 1 | 0 | 0 | 1 | 0 | | |
| Slovenia | X | 0 | 0 | 0 | 0 | 1 | 0 | | |
| Spain | X | 17 | 1 | 11 | 1 | 14 | 2 | X | XX |
| Sweden | X | 7 | 1 | 1 | 0 | 1 | 0 | | |
| Switzerland | | 1 | 1 | 2 | 1 | 9 | 0 | | |
| The Netherlands | X | 24 | 2 | 6 | 0 | 4 | 0 | | |
| Turkey | | 2 | 0 | 0 | 0 | 0 | 0 | | |
| UK-England | X | 11 | 3 | 3 | 0 | 11 | 1 | | X |
| UK-Northern Ireland | X | 0 | 0 | 0 | 0 | 1 | 0 | | |
| UK-Scotland | X | 6 | 1 | 2 | 1 | 1 | 1 | X | X |
| UK-Wales | X | 0 | 0 | 0 | 0 | 0 | 0 | | |
| European* | X | 2 | 0 | 9 | 1 | 1 | 1 | | |
| Total | | 165 | 29 | 130 | 12 | 111 | 15 | 5 | 10 |